Correction to: Nature Immunology https://doi.org/10.1038/s41590-023-01543-9. Published online 3 July 2023.
In the version of this article initially published, Ashmitaa Logandha Ramamoorthy Premlal (Division of Vaccine Discovery, La Jolla Institute for Immunology, La Jolla, CA, USA), who contributed to the bioinformatic analysis of TCR genes, was missing from the author list. In Fig. 4e, the red dotted key reading “0.3” appeared originally as “3”. In the Competing interests statement, Bjoern Peters was not listed as an inventor on patents related to tumor-specific TCRs. The HTML and PDF versions of the article are now updated with the changes.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Brightman, S.E., Becker, A., Thota, R.R. et al. Author Correction: Neoantigen-specific stem cell memory-like CD4+ T cells mediate CD8+ T cell-dependent immunotherapy of MHC class II-negative solid tumors. Nat Immunol 24, 1391 (2023). https://doi.org/10.1038/s41590-023-01591-1
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41590-023-01591-1
